C.ANIRUDH JAGANNADH, M.SRAVANI, and DR M.D DHANARAJU. “ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS”. International Journal of Pharma and Bio Sciences 4, no. 2 (June 30, 2013): 750–754. Accessed September 3, 2026. https://ijpbs.net/index.php/journal/article/view/2225.